The Eclipse Foundation releases an open-source framework to standardize how companies build and deploy AI agents across their operations.
GENFIT and EVerZom plan to run exploratory studies to assess efficacy for EViv in ACLF, with a clear decision point within 18 months on whether to advance into clinical development.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback